This article is more than 5 years old. Information may no longer be current.
FDA announces recall of certain MiniMed insulin pumps, market withdrawal of weight-loss drug — top stories in endocrinology
The FDA announced that Medtronic has recalled its 600 series of MiniMed insulin pumps due to a missing or broken retainer ring. It was the top story in endocrinology last week.
Another top story was about the voluntary withdrawal of the weight-loss drug lorcaserin (Belviq) that was pulled from the U.S. market after clinical trial data showed the drug was associated with an increased risk for cancer, according to the FDA.
Read these and more top stories in endocrinology below:
Medtronic recalls some MiniMed insulin pumps for incorrect dosing
Medtronic has recalled its 600 series of MiniMed insulin pumps due to a missing or broken retainer ring, which helps to lock the insulin cartridge in place in the pump’s reservoir compartment, according to the FDA. Read more.
FDA requests withdrawal of weight-loss drug due to cancer risk
The FDA requested that the manufacturer of the serotonin receptor agonist lorcaserin voluntarily withdraw the weight-loss drug from the U.S. market because of clinical trial data that show an increased occurrence of cancer, according to an agency alert issued last week. Read more.
Obesity-related health evaluations must include waist circumference
Clinicians should evaluate waist circumference in addition to BMI when determining obesity-related cardiometabolic risks, according to a consensus statement published in Nature Reviews Endocrinology. Read more.
Brown fat may hold key to treatment of cardiometabolic disorders
Healio spoke with an expert at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases branch about the role of brown fat in the human body, how our understanding of the organ has developed, how it may be utilized in obesity treatment and what we still need to learn. Read more.
Chemicals in cosmetics increase obesity risk for children exposed in utero
Children may be more likely to develop overweight or obesity if their mothers are exposed to high levels of paraben while pregnant, according to findings published in Nature Communications. Read more.